KDIGOAKI诊治规范专题知识 急性肾损伤诊治 KDIGO:KidneyDisease:ImprovingGlobalOutcomes,2023CLINICALPRACTICEGUIDELINESACUTEKIDNEYINJURY UKRenalAssociation5thEdition,2023 第1页 近年来，国内外学者对急性肾衰竭（ARF）旳概念进行了广泛而进一步旳论证。越来越
非奈利酮在其他方面也具有良好的耐受性,在2个大型试验中未发现严重AKI的额外风险。更多详情参见KDIGO 2022慢性肾脏病糖尿病管理临床实践指南。 与单独使用SGLT2i和非奈利酮相比,评估SGLT2i和非奈利酮联合使用效果的试验正在进行中(Clin-icalTrials.gov:NCT05254002)。尚未对与无糖尿病的CKD患者进行类固醇和nsMRA的有效...
AKI, acute kidney injury; CKD, chronic kidney disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; RAAS, renin–angiotensin-aldosterone system; SGLT2, sodium-glucose cotransporter-2. 10.2.2 Class I or Class II lupus nephritis Practice Point 10.2.2.1: ...
Comparison of cROCK, KDIGO, and Their Combined Criteria for Detecting AKI in Hospitalized Adults with CKDdoi:10.1681/ASN.20233411S1760bLing SunXuzhou Central Hospital, Xuzhou, China;Luxi ZouXuzhou Medical University, Xuzhou, China .American Society of Nephrology...
The international organization Kidney Disease: Improving Global Outcomes (KDIGO) has developed guidelines promulgating definitions and classifications for acute kidney injury (AKI), acute kidney diseases and disorders (AKD), and CKD, and guidelines for their evaluation and management.6,7 Developing consis...
非奈利酮在其他方面也具有良好的耐受性,在2个大型试验中未发现严重AKI的额外风险。更多详情参见KDIGO 2022慢性肾脏病糖尿病管理临床实践指南。 与单独使用SGLT2i和非奈利酮相比,评估SGLT2i和非奈利酮联合使用效果的试验正在进行中(Clin-icalTrials.gov:NCT05254002)。尚未对与无糖尿病的CKD患者进行类固醇和nsMRA的有效...
IgAN can also lead to acute kidney injury (AKI) from severe visible hematuria, in which case management should focus on supportive care for AKI. A repeat kidney biopsy should be considered in patients who fail to show improvement in kidney function within 2 weeks following cessation of the hema...
Abbreviations: AKI, acute kidney injury; CKD, chronic kidney disease; eCLcr, estimated creatinine clearance; eGFR, estimated glomerular filtration rate; mGFR, measured glomerular filtration rate. DRUG DOSING CONSIDERATIONS FOR PATIENTS WITH CKD Despite numerous published guidelines46., 47., 48., 49....